Mark Danta
Sydney
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile
Articles by Mark Danta
A triad of somatic mutagenesis converges in self-reactive B cells to cause a virus-induced autoimmune disease
Keywords hepatitis C virus cryoglobulinemic vasculitis somatic mutation B lymphocyte rheumatoid factor autoantibody antigenic mimicry antibody affinity superselectivity Introduction Viral infection is postulated to trigger many autoimmune diseases, yet their connection is poorly understood.
Patient‐driven personal importation in the face of cost barriers to care: can we do better?
References 1 Australian Bureau of Statistics. Patient Experiences, 2021-22 Financial Year [Internet]. 2022 [cited 2023 Jan 25]. Available from URL: https://www.abs.gov.au/statistics/health/health-services/patient-experiences/latest-release 2, , , . The incidence of personal importation of prescription medicines among Australians 45 and older: a cross-sectional survey. Aust Health Rev 2023; 47: 694–699. 3 Department of Health and Aged Care.
The Role of the Gastrointestinal Microbiome in Liver Disease
1. Introduction Liver disease causes approximately two million deaths a year, posing a significant global health problem [1]. This is the consequence of several aetiologies, including alcohol-related and metabolic-related disease, viral infections, cholestasis and immune disease, leading to fibrosis and, eventually, cirrhosis.
Effect of NSAIDs and APT on Incidence and Recurrence of HCC
close Please confirm that you would like to log out of Medscape. If you log out, you will be required to enter your username and password the next time you visit. Log out Cancel In This Article Abstract and Introduction Abstract Background: Chemoprevention with NSAIDs, including aspirin, and anti-platelet therapy (APT), has been suggested to reduce the incidence and recurrence of hepatocellular carcinoma (HCC).
Editorial: aspirin and NSAID for chemoprevention of hepatocellular carcinoma - ready for their use? Authors' reply
INVITED EDITORIAL Mark Danta, Corresponding Author m.danta@unsw.edu.au orcid.org/0000-0001-5551-6811 St Vincent’s Centre for Applied Medical Research, St Vincent’s Hospital, Sydney, NSW, Australia Faculty of Medicine and Health, St Vincent’s Clinical School, UNSW, Sydney, NSW, Australia Department of Gastroenterology and Hepatology, St Vincent’s Hospital, Sydney, NSW, Australia Search for more papers by this author Regina Zi Hwei Tan, Faculty of Medicine and Health, St Vincent’s Clinical...
Systematic review with meta‐analysis: The effects of non‐steroidal anti‐inflammatory drugs and anti‐platelet therapy on the incidence and recurrence of hepatocellular carcinoma
SYSTEMATIC REVIEW Regina Zi Hwei Tan, St Vincent's Clinical School, Faculty of Medicine and Health, UNSW, Sydney, NSW, Australia Search for more papers by this author Ian Lockart, St Vincent's Clinical School, Faculty of Medicine and Health, UNSW, Sydney, NSW, Australia St Vincent's Centre for Applied Medical Research, St Vincent's Hospital, Sydney, NSW, Australia Department of Gastroenterology and Hepatology, St Vincent's Hospital, Sydney, NSW, Australia Search for more papers by this author...
Effectiveness of DAA Treatment for HCV in Patients With HCC
Abstract and Introduction Abstract Background: Direct-acting antiviral (DAA) therapy for hepatitis C virus (HCV) infection is highly curative and tolerable. Among patients with hepatocellular carcinoma (HCC), optimal timing of DAA therapy remains unclear. Data on efficacy of DAA therapy in patients with HCC would inform this decision-making. Aim: To evaluate response to DAA therapy among patients diagnosed with HCV infection and HCC.
The safety and pharmacokinetics of metformin in patients with chronic liver disease
Summary Background The FDA approved ‘label’ for metformin lists hepatic insufficiency as a risk for lactic acidosis. Little evidence supports this warning. Aims To investigate the safety and pharmacokinetics of metformin in patients with chronic liver disease (CLD).
Systematic review with meta‐analysis: effectiveness of direct‐acting antiviral treatment for hepatitis C in patients with hepatocellular carcinoma
Summary Background Direct‐acting antiviral (DAA) therapy for hepatitis C virus (HCV) infection is highly curative and tolerable. Among patients with hepatocellular carcinoma (HCC), optimal timing of DAA therapy remains unclear. Data on efficacy of DAA therapy in patients with HCC would inform this decision‐making. Aim To evaluate response to DAA therapy among patients diagnosed with HCV infection and HCC. Methods Bibliographic databases and conference abstracts were searched.
Show More
loading
Actions
Is this you?
As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.Get in touch with Mark
Contact Mark, search articles and posts on X, monitor coverage, and track replies from one place.
Learn more about Muck Rack